These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 6123308

  • 41. Neuroreceptor autoradiography.
    Anderson WJ.
    Monogr Neural Sci; 1984; 10():120-39. PubMed ID: 6321968
    [No Abstract] [Full Text] [Related]

  • 42. Benzodiasepine and neurotransmitter receptor binding in rat brain after chronic administration of diazepam or phenobarbital.
    Möhler H, Okada T, Enna SJ.
    Brain Res; 1978 Nov 10; 156(2):391-5. PubMed ID: 30521
    [No Abstract] [Full Text] [Related]

  • 43. Neurotransmitter receptors on microglia.
    Liu H, Leak RK, Hu X.
    Stroke Vasc Neurol; 2016 Jun 10; 1(2):52-58. PubMed ID: 28959464
    [Abstract] [Full Text] [Related]

  • 44. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.
    Whitehouse PJ, Trifiletti RR, Jones BE, Folstein S, Price DL, Snyder SH, Kuhar MJ.
    Ann Neurol; 1985 Aug 10; 18(2):202-10. PubMed ID: 2994554
    [Abstract] [Full Text] [Related]

  • 45. Effect of focal cerebral ischaemia on modulatory neurotransmitter receptors in the rat brain: an autoradiographic study.
    Rogozinska K, Skangiel-Kramska J.
    J Chem Neuroanat; 2010 Nov 10; 40(3):232-8. PubMed ID: 20600826
    [Abstract] [Full Text] [Related]

  • 46. 6 -Hydroxydopamine decreases benzodiazepine but not GABA receptor binding in rat cerebellum.
    Doble A, Iversen LL, Bowery NG, Hill DR, Hudson AL.
    Neurosci Lett; 1981 Dec 11; 27(2):199-204. PubMed ID: 6119659
    [Abstract] [Full Text] [Related]

  • 47. Receptor-binding changes in copper-deficient rats.
    Geiger JD, Seth PK, Klevay LM, Parmar SS.
    Pharmacology; 1984 Dec 11; 28(4):196-202. PubMed ID: 6328549
    [Abstract] [Full Text] [Related]

  • 48. Absence of specific binding of several putative neuro-transmitters to human fibroblasts.
    Berrettini WH, Nadi NS, Gershon ES.
    J Recept Res; 1983 Dec 11; 3(3):409-21. PubMed ID: 6137566
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Transmitter receptor alterations in Parkinson's disease.
    Calne DB, Stoessl AJ.
    Adv Neurol; 1987 Dec 11; 45():45-9. PubMed ID: 2881449
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Palmitoylation of G-protein-coupled receptors: a dynamic modification with functional consequences.
    Bouvier M, Moffett S, Loisel TP, Mouillac B, Hebert T, Chidiac P.
    Biochem Soc Trans; 1995 Feb 11; 23(1):116-20. PubMed ID: 7758677
    [No Abstract] [Full Text] [Related]

  • 59. The nature of receptors regulating the formation of cyclic AMP in brain tissue.
    Daly JW.
    Life Sci; 1976 Jun 15; 18(12):1349-58. PubMed ID: 7721
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.